UnitedHealthcare
Vizimpro (dacomitinib)
Drugs for Cancer : Drugs for Cancer
  • PA Applies
  • PA Applies
  • Quantity Limit: limit maximum 30 day(s) supply limit maximum 15 EA PER fill retail
  • Derm: Acne Vulgaris:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Limited to non-cosmetic use: No